中文名称  心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 

英文名称  Anti-Ryanodine Receptor

别    名 Arrhythmogenic right ventricular dysplasia 2; ARVC 2; ARVC2; ARVD 2; ARVD2; Brain ryanodine receptor calcium release channel; Brain type ryanodine receptor; Cardiac muscle ryanodine receptor; Cardiac muscle ryanodine receptor calcium release channel; Cardiac muscle type ryanodine receptor; CCO; Central core disease of muscle; HBRR; hRYR 2; hRYR2; MHS; MHS1; Ryanodine receptor 1 (skeletal); Ryanodine receptor 1; Ryanodine receptor 2 (cardiac); Ryanodine receptor 2; Ryanodine receptor 3; Ryanodine receptor type1; RYDR; RYR 1; RYR 2; RYR 3; RYR; RYR1; RYR2; RYR3; Sarcoplasmic reticulum calcium release channel; Skeletal muscle calcium release channel; Skeletal muscle ryanodine receptor; Skeletal muscle type ryanodine receptor; SKRR; Type 1 like ryanodine receptor; VTSIP.

产品属性：

心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 浓    度  1mg/1ml

规 格  0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Rabbit

产品类型   一抗  

研究领域     心 通道蛋白 细胞膜受体

蛋白分子量  predicted molecular weight: 566kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Ryanodine Receptor

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 产品应用   ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 The Ryanodine Receptor (RyR) is the channel responsible for calcium release from muscle cell Sarcoplasmic Reticulum (SR) and also plays a role in calcium regulation in non-muscle cells. The RyR exists as a homotetramer and is predicted to have a short cytoplasmic C-terminus and 4-10 transmembrane domains. The remainder of the protein, termed the "foot" region, is located in the cytoplasm between the transverse tubule and the SR. Mammalian RyR isoforms are the product of three different genes: RyR-1 is expressed predominantly in skeletal muscle and areas of the brain; RyR-2 is expressed predominantly in heart muscle but also found in the stomach, endothelial cells and diffuse areas of the brain; and RyR-3 is found in smooth muscle and the brain (striatum, thalamus and hippocampus). In non-mammalian vertebrates, the RyR isoforms are termed alpha, beta and cardiac which correlate loosely to the mammalian RyR-1, RyR-3 and RyR-2 isoforms respectively.

Function : Calcium channel that mediates the release of Ca(2+) fromthe sarcoplasmic reticulum into the cytoplasm and thereby plays akey role in triggering muscle contraction following depolarizationof T-tubules. Repeated very high-level exercise increases the openprobability of the channel and leads to Ca(2+) leaking into thecytoplasm. Can also mediate the release of Ca(2+) fromintracellular stores in neurons, and may thereby promote prolongedCa(2+) signaling in the brain. Required for normal embryonicdevelopment of muscle fibers and skeletal muscle. Required fornormal heart morphogenesis, skin development and ossificationduring embryogenesis (By similarity).

Subunit : Homotetramer. Can also form heterotetramers with RYR2.Interacts with CALM; CALM with bound calcium inhibits the RYR1channel activity. Interacts with S100A1. Interacts with FKBP1A;this stabilizes the closed conformation of the channel. Interactswith CACNA1S; interaction with CACNA1S is important for activationof the RYR1 channel. Interacts with CACNB1. Interacts with TRDN andASPH; these interactions stimulate RYR1 channel activity (Bysimilarity). Identified in a complex composed of RYR1, PDE4D, PKA,FKBP1A and protein phosphatase 1 (PP1). Repeated very high-levelexercise decreases interaction with PDE4D and protein phosphatase 1(PP1).

Subcellular Location : Sarcoplasmic reticulum membrane; Multi-pass membrane protein (Probable). Membrane; Multi-pass membrane protein. Microsome membrane; Multi-pass membrane protein.

Tissue Specificity : Brain, skeletal muscle, placenta and possibly liver and kidney. In brain, highest levels are found in the cerebellum, hippocampus, caudate nucleus and amygdala, with lower levels in the corpus callosum, substantia nigra and thalamus.

Post-translational modifications : Channel activity is modulated by phosphorylation.Phosphorylation at Ser-2843 may increase channel activity. Repeatedvery high-level exercise increases phosphorylation at Ser-2843.[PTM] Activated by reversible S-nitrosylation. Repeated veryhigh-level exercise increases S-nitrosylation.

DISEASE : Malignant hyperthermia 1 (MHS1) [MIM:145600]: Autosomaldominant pharmacogenetic disorder of skeletal muscle and is one ofthe main causes of death due to anesthesia. In susceptible people,an MH episode can be triggered by all commonly used inhalationalanesthetics such as halothane and by depolarizing muscle relaxantssuch as succinylcholine. The clinical features of the myopathy arehyperthermia, accelerated muscle metabolism, contractures,metabolic acidosis, tachycardia and death, if not treated with thepostsynaptic muscle relaxant, dantrolene. Susceptibility to MH canbe determined with the 'in vitro' contracture test (IVCT):observing the magnitude of contractures induced in strips of muscletissue by caffeine alone and halothane alone. Patients with normalresponse are MH normal (MHN), those with abnormal response tocaffeine alone or halothane alone are MH equivocal (MHE(C) andMHE(H) respectively). Note=The disease is caused by mutationsaffecting the gene represented in this entry.

Central core disease of muscle (CCD) [MIM:117000]:Autosomal dominant congenital myopathy, but a severe autosomalrecessive form also exists. Both clinical and histologicalvariability is observed. Affected individuals typically displayhypotonia and proximal muscle weakness in infancy, leading to thedelay of motor milestones. The clinical course of the disorder isusually slow or nonprogressive in adulthood, and the severity ofthe symptoms may vary from normal to significant muscle weakness.Microscopic examination of CCD-affected skeletal muscle reveals apredominance of type I fibers containing amorphous-looking areas(cores) that do not stain with oxidative and phosphorylasehistochemical techniques. Note=The disease is caused by mutationsaffecting the gene represented in this entry.

Multiminicore disease with external ophthalmoplegia(MMDO) [MIM:255320]: Clinically heterogeneous neuromusculardisorder. General features include neonatal hypotonia, delayedmotor development, and generalized muscle weakness and amyotrophy,which may progress slowly or remain stable. Muscle biopsy showsmultiple, poorly circumscribed, short areas of sarcomeredisorganization and mitochondria depletion (areas termed minicores)in most muscle fibers. Typically, no dystrophic signs, such asmuscle fiber necrosis or regeneration or significant endomysialfibrosis, are present in multiminicore disease. Note=The disease iscaused by mutations affecting the gene represented in this entry.

Congenital myopathy with fiber-type disproportion (CFTD)[MIM:255310]: Genetically heterogeneous disorder in which there isrelative hypotrophy of type 1 muscle fibers compared to type 2fibers on skeletal muscle biopsy. However, these findings are notspecific and can be found in many different myopathic andneuropathic conditions. Note=The disease is caused by mutationsaffecting the gene represented in this entry.

Note=Defects in RYR1 may be a cause of Samaritanmyopathy, a congenital myopathy with benign course. Patientsdisplay severe hypotonia and respiratory distress at birth. Unlikeother congenital myopathies, the health status constantly improvesand patients are minimally affected at adulthood.

Similarity : Belongs to the ryanodine receptor (TC 1.A.3.1) family. RYR3 subfamily.

Contains 3 B30.2/SPRY domains.

Contains 5 MIR domains.

Database links : UniProtKB/Swiss-Prot: P21817.3

Defects in the RYR2 gene are the cause of several heart diseases: 1) familial arrhythmogenic right ventricular dysplasia 2 (ARVD2), also known as arrhythmogenic right ventricular cardiomyopathy 2 (ARVC2), 2) an autosomal dominant form of stress-induced polymorphic ventricular tachycardia (VTSIP), also known as catecholaminergic polymorphic ventricular tachycardia (CPVT) and 3) familial polymorphic ventricular tachycardia (FPVT). Ryanodine Receptor 2 contains several phosphorylatable sites. Specifically, Ser-2030 and Ser-2809 (or at Ser-2808 depending on the species) can be phosphoryated by protein kinase A (PKA) and Ser-2815 (or at Ser-2814 depending on the species) can be phosphorylated by CaMKII (Ca2+/calmodulin-dependent protein kinase II).

实验流程：

全、新、优、品、好四大特点：

心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

★心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品：

LRP/MVP (Lung resistance related protein) 肺耐药相关蛋白(抗原)Multi-class antibodies规格： 0.5mg

Anti-CR1/CD35 Ⅰ型补体受体抗体(C3b/C4b受体抗体)Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh PABP 多聚腺苷酸结合蛋白抗体 规格 0.1ml

STK4 Kit Human 人 STK4 / MST1 ELISA配对抗体 ELISA

TUBA4A 英文名称： 微管蛋白4α抗体 0.1ml

CD73 英文名称： CD73抗体 0.2ml

Anti-CR1/CD35 Ⅰ型补体受体抗体(C3b/C4b受体抗体)Multi-class antibodies规格： 0.2ml

Anti-Regucalcin/SMP30/Rgn/FITC 荧光素标记衰老标记蛋白30抗体IgGMulti-class antibodies规格： 0.2ml

Bursin 囊素三肽/三肽囊素/鸡法氏囊三肽Multi-class antibodies规格： 100mg

抗蚯蚓纤溶酶抗体/抗蚓激酶抗体 Anti-Lumbrokinase 0.1ml

Selenium Binding Protein 1 英文名称： 硒结合蛋白1抗体 0.2ml

FOXB1 + FOXB2 英文名称： 叉头蛋白B1+B2抗体 0.2ml

Rhesus antibody Rh Phospho-PKC gamma (Thr514) 磷酸化蛋白激酶C亚型G抗体 规格 0.1ml

Bursin 囊素三肽/三肽囊素/鸡法氏囊三肽Multi-class antibodies规格： 100mg

IL-11 小鼠白介素-11Multi-class antibodies规格： 48T

Anti-ERK2/MAPK1 原活化蛋白激酶1抗体Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh MT-ND1 NADH复合体1抗体 规格 0.2ml

F X III (Human coagulation factor X III ) ELISA Kit 人凝血因子ⅩⅢ 96T

Striatin 3 英文名称： 细胞周期蛋白SG2N抗体 0.2ml

connexin 30 英文名称： 间隙连接蛋白30抗体 0.1ml

Anti-ERK2/MAPK1 原活化蛋白激酶1抗体Multi-class antibodies规格： 0.1ml

布氏琼脂250g用于弯曲杆菌的抗生素敏感性试验和纯化培养。

ISP培养基 250g 用于链霉菌的培养

李氏菌增菌肉汤(LB1,LB2)基础 Listeria Enrichment Broth Base 250 添加奈啶酮酸，黄素，即为LB1，LB2，用于李氏菌二步增菌(GB标准)

卵黄氯琼脂培养基250g/瓶用于金黄色葡萄球菌选择性分离，每65ml培养基中添加2支20804incubationmedia卵黄氯琼脂培养基250g/瓶用于金黄色葡萄球菌选择性分离，每65ml培养基中添加2支20804

MUG快速鉴定大肠试剂 5ml*10支/盒 用于快速鉴定大肠杆菌

水稻水培养液250g用于水稻的水培养液

金黄色葡萄球菌显色培养基 用于金黄色葡萄球菌的鉴定和计数 1000ml incubation media 金黄色葡萄球菌显色培养基 用于金黄色葡萄球菌的鉴定和计数 1000ml

宽鳞大孔菌 啤酒 (下层酵母)。 支/瓶

MUG

1%Tween80-CornAgarMedium

心肌兰尼碱受体抗体（脑肌兰尼碱受体）品牌 氧气指示剂  规格：  10片/包  用途：  一片/次，可重复

3.5L厌氧产气剂  规格：  10袋/包  用途：  严格厌氧菌培养：每袋用于3.5L厌氧体积。

2.5LCO2产气剂  规格：  10袋/包  用途：  嗜二氧化碳菌培养：每袋用于2.5L厌氧体积。

2.5L微需氧产气剂  规格：  10袋/包  用途：  微需氧菌培养：每袋用于2.5L厌氧体积。